Abstract:Antimicrobial resistance is a global concern in chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD). The collection of antibiotic resistance genes or resistome in human airways may underlie the resistance. COPD is heterogeneous, and understanding the airway resistome in relation to patient phenotype and endotype may inform precision antibiotic therapy. Here, we characterized the airway resistome for 94 COPD participants at stable disease. Among all demographic and clinical factors, patient inflammatory endotype was associated with the airway resistome. There were distinct resistome profiles between patients with neutrophilic or eosinophilic inflammation, two primary inflammatory endotypes in COPD. For neutrophil-predominant COPD, the resistome was dominated by multidrug resistance genes. For eosinophil-predominant COPD, the resistome was diverse, with an increased portion of patients showing a macrolide-high resistome. The differential antimicrobial resistance pattern was validated by sputum culture and in vitro antimicrobial susceptibility testing. Ralstonia and Pseudomonas were the top contributors to the neutrophil-associated resistome, whereas Campylobacter and Aggregatibacter contributed most to the eosinophil-associated resistome. Multiomic analyses revealed specific host pathways and inflammatory mediators associated with the resistome. The arachidonic acid metabolic pathway and matrix metallopeptidase 8 (MMP-8) exhibited the strongest associations with the neutrophil-associated resistome, whereas the eosinophil chemotaxis pathway and interleukin-13 (IL-13) showed the greatest associations with the eosinophil-associated resistome. These results highlight a previously unrecognized link between inflammation and the airway resistome and suggest the need for considering patient inflammatory subtype in decision-making about antibiotic use in COPD and broader chronic respiratory diseases. IMPORTANCE Antibiotics are commonly prescribed for both acute and long-term prophylactic treatment in chronic airway disorders, such as chronic obstructive pulmonary disease (COPD), and the rapid growth of antibiotic resistance is alarming globally. The airway harbors a diverse collection of microorganisms known as microbiota, which serve as a reservoir for antibiotic resistance genes or the resistome. A comprehensive understanding of the airway resistome in relation to patient clinical and biological factors may help inform decisions to select appropriate antibiotics for clinical therapies. By deep multiomic profiling and in vitro phenotypic testing, we showed that inflammatory endotype, the underlying pattern of airway inflammation, was most strongly associated with the airway resistome in COPD patients. There were distinct resistome profiles between neutrophil-predominant and eosinophil-predominant COPD that were associated with different bacterial species, host pathways, and inflammatory markers, highlighting the need of considering patient inflammatory status in COPD antibiotic management.

Presence of antibiotic resistance genes in the lower airways microbiome of patients with chronic lung disease and healthy controls

Differential airway resistome and its correlations with clinical characteristics in Haemophilus- or Pseudomonas-predominant microbial subtypes of bronchiectasis

The Abundance and Diversity of Antibiotic Resistance Genes in the Atmospheric Environment of Biology Laboratories and Surroundings

Spread of antibiotic resistance genes and microbiota in airborne particulate matter, dust, and human airways in the urban hospital

Airway ‘Resistotypes’ and Clinical Outcomes in Bronchiectasis

Global genomic diversity of Pseudomonas aeruginosa in bronchiectasis

Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome

Antibiotic Resistance Genes and Antibiotic Sensitivity in Bacterial Aerosols and Their Comparisons with Known Respiratory Pathogens

Short-term Inhalation Exposure Evaluations of Airborne Antibiotic Resistance Genes in Environments

The antibiotic resistance reservoir of the lung microbiome expands with age in a population of critically ill patients

Global Survey of Antibiotic Resistance Genes in Air

Metagenomic airborne resistome from urban hot spots through the One Health lens

Inhalable antibiotic resistomes emitted from hospitals: metagenomic insights into bacterial hosts, clinical relevance, and environmental risks

Inflammatory Endotype-Associated Airway Resistome in Chronic Obstructive Pulmonary Disease

Impact of prophylactic and 'rescue pack' antibiotics on the airway microbiome in chronic lung disease

Prevalence Of Antibiotic Resistance Genes In Air-Conditioning Systems In Hospitals, Farms, And Residences

Microbiological characteristics of the lower airway in adults with bronchiectasis: a prospective cohort study

Metagenomic Analysis Reveals the Distribution of Antibiotic Resistance Genes in a Large-Scale Population of Healthy Individuals and Patients With Varied Diseases

Genomic diversity and antimicrobial resistance of Prevotella species isolated from chronic lung disease airways

Polymicrobial Airway Bacterial Communities in Adult Bronchiectasis Patients

Distribution of antibiotic resistance genes and bacteria from six atmospheric environments: Exposure risk to human.